BFG
ENFN

Bleakley Financial Group’s Enfusion, Inc. ENFN Stock Holding History

Bleakley Financial Group’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19,054
Closed -$176K – 1075
2024
Q1 		$176K Buy
+19,054
New +$168K 0.01% 904

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Ararat Capital Management Westport, Connecticut $178M AUM 26.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
NCM
Nellore Capital Management Redwood City, California $783M AUM 2.58% 1-Year Est. Return
LECM
Lead Edge Capital Management New York $408M AUM 4.05% 1-Year Est. Return

Bleakley Financial Group's ENFN Position: Q2 2024 in Review

Bleakley Financial Group sold out of Enfusion, Inc. (ENFN) in Q2 2024, closing a stake of 19,054 shares — an estimated $176K sold.

Bleakley Financial Group first reported a position in ENFN in Q1 2024 and held it in 1 quarter. The position peaked at $176K in Q1 2024. 101 funds tracked by Wall St. Rank hold ENFN as of Q2 2024.

  • Bleakley Financial Group reported no remaining Enfusion, Inc. position as of Q2 2024 after selling out during the quarter.
  • Bleakley Financial Group sold 19,054 Enfusion, Inc. shares in Q2 2024, an estimated $176K.
  • Bleakley Financial Group first reported a position in Enfusion, Inc. in Q1 2024 and held it in 1 quarter.
  • Bleakley Financial Group's Enfusion, Inc. position peaked at $176K in Q1 2024.
  • 101 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2024.

Based on Bleakley Financial Group's 13F filing for Q2 2024, filed 12 Aug 2024.